Nick Haft Overview

  • Primary Position
  • Managing Directo...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 4

  • Med. Deal Size

Nick Haft General Information

Biography

Mr. Nick Haft serves as Managing Director at OMX Ventures. He is a Co-Founder and serves as a Board Member at Delix Therapeutics. He serves as a Board Observer at Replay Therapeutics. He serves as a Board Member at VedaBio & Freya Biosciences. He was the sole managing partner at Arcos Ventures, where he deployed over $80M of capital into 20+ bio-related companies. Some of his prior investments include Finch Therapeutics, Pendulum Therapeutics, Ginkgo Bioworks, 10X Genomics, Imagen, Compass Pathways, and many others. He also co-founded Delix Therapeutics, a startup that developed breakthrough therapies for psychiatric and neurological disorders. He holds a Bachelor of Science in Economics, from the Wharton School, University of Pennsylvania.

Contact Information

Primary Position
Managing Director, OMX Ventures
Education
University of Pennsylvania (Wharton), BS (Bachelor of Science)
Gender
Male
Email
ni
Phone
+1 (415)
Address
  • One Overlock Point
  • Suite 100
  • Lincolnshire, IL 60069
  • United States
+1 (415)

Nick Haft Positions (2)

Firm name Firm type Title Location Industry Since
Delix Company Co-Founder & Board Member Bedford, MA Drug Discovery
OMX Ventures Investor Managing Director Lincolnshire, IL Venture Capital

Nick Haft Board Seats (4)

Company Industry Ownership Status Financing Status Location Since
Delix Drug Discovery Privately Held (backing) Venture Capital-Backed Bedford, MA
Freya Biosciences Biotechnology Privately Held (backing) Venture Capital-Backed Copenhagen, Denmark
Replay (Drug Discovery) Drug Discovery Privately Held (backing) Venture Capital-Backed San Diego, CA
VedaBio Diagnostic Equipment Privately Held (backing) Venture Capital-Backed San Diego, CA

Nick Haft Lead Partner on Deals (4)

Nick Haft has been the lead partner on 4 deals. Their latest deal was with Freya Biosciences, a biotechnology company. The deal was made for on 12-Dec-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Freya Biosciences 12-Dec-2023 Early Stage VC (Series A) Completed Biotechnology Copenhagen, Denmark
Replay (Drug Discovery) 25-Jul-2022 Completed Drug Discovery San Diego, CA
Delix 10-Jan-2022 Early Stage VC (Series B) Completed Drug Discovery Bedford, MA
Finch Therapeutics 15-Sep-2020 Later Stage VC (Series D) Completed Drug Discovery Boston, MA

Nick Haft Network (87)

Board Members (22)

Name Company Representing Location From
Swetha Murali Ph.D VedaBio OMX Ventures San Diego, CA
Mark Smith Freya Biosciences Self Copenhagen, Denmark
Freya Biosciences Self Copenhagen, Denmark
Delix Delix Bedford, MA
Delix ARTIS Ventures Bedford, MA

Portfolio Executives (65)

Name Company Role Deal date Location
Randi Rich Freya Biosciences Co-Founder, Head Of Operations & Director 12-Dec-2023 Copenhagen, Denmark
Crilles Larsen Ph.D Freya Biosciences Chief Technology Officer 12-Dec-2023 Copenhagen, Denmark
Freya Biosciences Co-Founder 12-Dec-2023 Copenhagen, Denmark
Freya Biosciences Chief Medical Officer 12-Dec-2023 Copenhagen, Denmark
Freya Biosciences Co-Founder & Chief Business Officer 12-Dec-2023 Copenhagen, Denmark

Nick Haft FAQs

  • Who is Nick Haft?

    Mr. Nick Haft serves as Managing Director at OMX Ventures.

  • How much does Nick Haft typically invest?

    Nick Haft's median deal size is .

  • What is Nick Haft’s main position?

    Nick Haft’s primary position is Managing Director.

  • What are the contact details for Nick Haft?

    Nick Haft’s email address is ni and his phone number is +1 (415) .

  • How many active board seats does Nick Haft hold?

    Nick Haft holds 4 board seats including Delix, Freya Biosciences, Replay (Drug Discovery), and VedaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »